We therefore expect that the amphibian IFN complex may have evolved IFN molecules bearing superior antitumor activity, and the Xenopus tumor immunity model can contribute to the development of IFN-based cancer immunotherapies [6,35]. This evidence concerns the gene IFNA1 and neoplasm.